Miral Dizdaroglu1, Erdem Coskun2, Pawel Jaruga2. 1. Biomolecular Measurement Division, National Institute of Standards and Technology, 100 Bureau Drive, MS 8315, Gaithersburg, MD 20899, USA. Electronic address: miral@nist.gov. 2. Biomolecular Measurement Division, National Institute of Standards and Technology, 100 Bureau Drive, MS 8315, Gaithersburg, MD 20899, USA.
Abstract
Endogenous and exogenous reactive species cause oxidatively induced DNA damage in living organisms by a variety of mechanisms. As a result, a plethora of mutagenic and/or cytotoxic products are formed in cellular DNA. This type of DNA damage is repaired by base excision repair, although nucleotide excision repair also plays a limited role. DNA glycosylases remove modified DNA bases from DNA by hydrolyzing the glycosidic bond leaving behind an apurinic/apyrimidinic (AP) site. Some of them also possess an accompanying AP-lyase activity that cleaves the sugar-phosphate chain of DNA. Since the first discovery of a DNA glycosylase, many studies have elucidated the mechanisms of action, substrate specificities and excision kinetics of these enzymes present in all living organisms. For this purpose, most studies used single- or double-stranded oligodeoxynucleotides with a single DNA lesion embedded at a defined position. High-molecular weight DNA with multiple base lesions has been used in other studies with the advantage of the simultaneous investigation of many DNA base lesions as substrates. Differences between the substrate specificities and excision kinetics of DNA glycosylases have been found when these two different substrates were used. Some DNA glycosylases possess varying substrate specificities for either purine-derived lesions or pyrimidine-derived lesions, whereas others exhibit cross-activity for both types of lesions. Laboratory animals with knockouts of the genes of DNA glycosylases have also been used to provide unequivocal evidence for the substrates, which had previously been found in in vitro studies, to be the actual substrates in vivo as well. On the basis of the knowledge gained from the past studies, efforts are being made to discover small molecule inhibitors of DNA glycosylases that may be used as potential drugs in cancer therapy. Published by Elsevier B.V.
Endogenous and exogenous reactive species capan>use oxipn>an>n class="Chemical">datively induced DNAdamage in living organisms by a variety of mechanisms. As a result, a plethora of mutagenic and/or cytotoxic products are formed in cellular DNA. This type of DNA damage is repaired by base excision repair, although nucleotide excision repair also plays a limited role. DNA glycosylases remove modified DNA bases from DNA by hydrolyzing the glycosidic bond leaving behind an apurinic/apyrimidinic (AP) site. Some of them also possess an accompanying AP-lyase activity that cleaves the sugar-phosphate chain of DNA. Since the first discovery of a DNA glycosylase, many studies have elucidated the mechanisms of action, substrate specificities and excision kinetics of these enzymes present in all living organisms. For this purpose, most studies used single- or double-stranded oligodeoxynucleotides with a single DNA lesion embedded at a defined position. High-molecular weight DNA with multiple base lesions has been used in other studies with the advantage of the simultaneous investigation of many DNA base lesions as substrates. Differences between the substrate specificities and excision kinetics of DNA glycosylases have been found when these two different substrates were used. Some DNA glycosylases possess varying substrate specificities for either purine-derived lesions or pyrimidine-derived lesions, whereas others exhibit cross-activity for both types of lesions. Laboratory animals with knockouts of the genes of DNA glycosylases have also been used to provide unequivocal evidence for the substrates, which had previously been found in in vitro studies, to be the actual substrates in vivo as well. On the basis of the knowledge gained from the past studies, efforts are being made to discover small molecule inhibitors of DNA glycosylases that may be used as potential drugs in cancer therapy. Published by Elsevier B.V.
Entities:
Keywords:
DNA glycosylases; DNA repair; Excision kinetics; Oxidatively induced DNA damage; Substrate specificities
Authors: Elena I Zaika; Rebecca A Perlow; Eileen Matz; Suse Broyde; Rotem Gilboa; Arthur P Grollman; Dmitry O Zharkov Journal: J Biol Chem Date: 2003-11-07 Impact factor: 5.157
Authors: Jingping Hu; Nadja C de Souza-Pinto; Kazuhiro Haraguchi; Barbara A Hogue; Pawel Jaruga; Marc M Greenberg; Miral Dizdaroglu; Vilhelm A Bohr Journal: J Biol Chem Date: 2005-10-11 Impact factor: 5.157
Authors: Victoria Valinluck; Pingfang Liu; Joseph I Kang; Artur Burdzy; Lawrence C Sowers Journal: Nucleic Acids Res Date: 2005-05-25 Impact factor: 16.971
Authors: Lavinia C Dumitrache; Mikio Shimada; Susanna M Downing; Young Don Kwak; Yang Li; Jennifer L Illuzzi; Helen R Russell; David M Wilson; Peter J McKinnon Journal: Proc Natl Acad Sci U S A Date: 2018-12-11 Impact factor: 11.205
Authors: Irina G Minko; Vladimir L Vartanian; Naoto N Tozaki; Oskar K Linde; Pawel Jaruga; Sanem Hosbas Coskun; Erdem Coskun; Chunfeng Qu; Huan He; Chungui Xu; Taoyang Chen; Qianqian Song; Yuchen Jiao; Michael P Stone; Martin Egli; Miral Dizdaroglu; Amanda K McCullough; R Stephen Lloyd Journal: DNA Repair (Amst) Date: 2019-05-03
Authors: Irina G Minko; Vladimir L Vartanian; Naoto N Tozaki; Erdem Coskun; Sanem Hosbas Coskun; Pawel Jaruga; Jongchan Yeo; Sheila S David; Michael P Stone; Martin Egli; Miral Dizdaroglu; Amanda K McCullough; R Stephen Lloyd Journal: DNA Repair (Amst) Date: 2019-11-02
Authors: Nichole Owen; Irina G Minko; Samantha A Moellmer; Sydney K Cammann; R Stephen Lloyd; Amanda K McCullough Journal: Proc Natl Acad Sci U S A Date: 2021-03-16 Impact factor: 11.205
Authors: Rachana Tomar; Irina G Minko; Andrew H Kellum; Markus W Voehler; Michael P Stone; Amanda K McCullough; R Stephen Lloyd Journal: Chem Res Toxicol Date: 2021-02-17 Impact factor: 3.739